Neurocrine Biosciences Stock Forecast - Day Median Price
| NBIX Stock | USD 138.89 2.90 2.13% |
Neurocrine Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Neurocrine Biosciences stock prices and determine the direction of Neurocrine Biosciences's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Neurocrine Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Neurocrine Biosciences' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Neurocrine Biosciences' systematic risk associated with finding meaningful patterns of Neurocrine Biosciences fundamentals over time.
Check out Historical Fundamental Analysis of Neurocrine Biosciences to cross-verify your projections. Neurocrine |
Open Interest Against 2024-05-17 Neurocrine Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Neurocrine Biosciences' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Neurocrine Biosciences' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Neurocrine Biosciences stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Neurocrine Biosciences' open interest, investors have to compare it to Neurocrine Biosciences' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Neurocrine Biosciences is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Neurocrine. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Neurocrine Biosciences cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Neurocrine Biosciences' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Neurocrine Biosciences' price structures and extracts relationships that further increase the generated results' accuracy.
Median Price is the statistical median of an asset price for a given trading period.| Previous Day Median Price | Day Median Price | Trend |
| 136.9 | 137.71 |
| Check Neurocrine Biosciences Volatility | Backtest Neurocrine Biosciences | Information Ratio |
Neurocrine Biosciences Trading Date Momentum
| On April 29 2024 Neurocrine Biosciences was traded for 138.89 at the closing time. The top price for the day was 139.37 and the lowest listed price was 136.05 . The trading volume for the day was 681.7 K. The trading history from April 29, 2024 did not cause price change. The trading delta at closing time against the current closing price is 2.04% . |
The median price is the midpoint of the trading periods range.
| Compare Neurocrine Biosciences to competition |
Other Forecasting Options for Neurocrine Biosciences
For every potential investor in Neurocrine, whether a beginner or expert, Neurocrine Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neurocrine Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neurocrine. Basic forecasting techniques help filter out the noise by identifying Neurocrine Biosciences' price trends.Neurocrine Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurocrine Biosciences stock to make a market-neutral strategy. Peer analysis of Neurocrine Biosciences could also be used in its relative valuation, which is a method of valuing Neurocrine Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neurocrine Biosciences Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neurocrine Biosciences' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neurocrine Biosciences' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Neurocrine Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Neurocrine Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurocrine Biosciences shares will generate the highest return on investment. By undertsting and applying Neurocrine Biosciences stock market strength indicators, traders can identify Neurocrine Biosciences entry and exit signals to maximize returns.
Neurocrine Biosciences Risk Indicators
The analysis of Neurocrine Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neurocrine Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurocrine stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.21 | |||
| Standard Deviation | 1.6 | |||
| Variance | 2.56 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Neurocrine Biosciences to cross-verify your projections. For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Neurocrine Stock analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Neurocrine Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurocrine Biosciences. If investors know Neurocrine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurocrine Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.648 | Earnings Share 2.48 | Revenue Per Share 19.315 | Quarterly Revenue Growth 0.25 | Return On Assets 0.0878 |
The market value of Neurocrine Biosciences is measured differently than its book value, which is the value of Neurocrine that is recorded on the company's balance sheet. Investors also form their own opinion of Neurocrine Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Neurocrine Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurocrine Biosciences' market value can be influenced by many factors that don't directly affect Neurocrine Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurocrine Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurocrine Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurocrine Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.